Article
NF-κB in the crosshairs: Rethinking an old riddle
23 Dec 2017
Abstract excerpt
Constitutive NF-κB signalling has been implicated in the pathogenesis of most human malignancies and virtually all non-malignant pathologies. Accordingly, the NF-κB pathway has been aggressively pursued as an attractive therapeutic target for drug discovery. However, the severe on-target toxicities associated with systemic NF-κB inhibition have thus far precluded the development of a clinically useful,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
